ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2645

The Transcription Factor Mohawk Plays an Important Role for Maintaining Human Anterior Cruciate Ligament Homeostasis

Hiroyuki Nakahara1, Akihiko Hasegawa1, Fumiaki Ayabe1, Tetsuya Matsukawa1, Koji Otabe1, Tomo Yonezawa1, Martin K. Lotz1 and Hiroshi Asahara2, 1Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, 2Molecular & Experimental Med, The Scripps Research Institute, La Jolla, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cell biology and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Recently Mohawk homeobox (MKX) has been discovered as a tendon and ligament specific transcriptional factor. MKX deficient-mice are shown to hypoplastic tendons throughout the body by down regulating changing type I collagen production in tendon cells. However, in human tendons or ligaments, little is known about the function of MKX. In this study, we demonstrated using human anterior cruciate ligament (ACL) tissues and primary cultured human ACL cells that MKX is an important regulator of human ligament homeostasis, and that its changes in the expression and function play an important role in ligament degeneration. The aims of this study are to characterize the expression of MKX in normal human knee joints and osteoarthritis (OA) affected knee joints and to investigate the role of MKX in human ligament homeostasis.

Methods: Human ACL specimens were obtained from the knee joints at cadaveric autopsy within 24-48 hours postmortem with approval of the Scripps Human Subjects Committee. 7 normal donors (mean±SD age 33.57±11.67years) and 8 donors with OA (mean±SD age 77.50±11.46 years) were analyzed and none of the donors had a history of knee joint trauma. All cartilage surfaces were graded macroscopically. ACL degeneration was assessed macroscopically and histologically using quantitative scoring systems. ACL tissues were analyzed for the expression of MKX by immunohistochemistry and quantitative RT-PCR assays. Primary cultured human ACL cells were stimulated with IL-1β to examine whether pro-inflammatory cytokine modulates MKX expression. Moreover, in order to examine the function of MKX on ECM production and differentiation in these cells, we performed the knocked-down by MKX specific siRNA and then, determined the expression of some genes involving in ECM and the differentiation using quantitative RT-PCR and western blotting analysis. 

Results: The expression of MKX was remarkably decreased during developing OA. In addition, the expression of COL1a1, which is major component of ACL, is also decreased in OA group. In coincidence with the result of immunohistochemistry revealed that the percentage of MKX positive cells was significantly reduced in OA group. In primary cultured human ACL cells, the expression of MKX was significantly reduced by the treatment of IL-1β. The expression of genes involving in regulating ECM homeostasis such as COL1a1 and TNXb and transcriptional factor Scleraxis (SCX), which is specific regulator of the tendon/ligament lineage, were down-regulated by IL-1β treatment. On the other hand, SOX9, which is involved in the modulation of chondrocyte like phenotype, was up-regulated by IL-1β treatment. The expression of COL1a1 and TNXb were decreased by MKX specific siRNA treatment, though that of SOX9 was increased. We didn’t detect any significant differences in those of SCX, IL-6 and MMP13.

Conclusion: To our knowledge, this is the first report to investigate the MKX expression and function in Human ligaments. The present study demonstrates that the expression of MKX is down-regulated by an inflammatory response and MKX may play important roles in ligament homeostasis via regulating the expression of COL1a1, TNXb and SOX9 in human ACL cells.


Disclosure:

H. Nakahara,
None;

A. Hasegawa,
None;

F. Ayabe,
None;

T. Matsukawa,
None;

K. Otabe,
None;

T. Yonezawa,
None;

M. K. Lotz,
None;

H. Asahara,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-transcription-factor-mohawk-plays-an-important-role-for-maintaining-human-anterior-cruciate-ligament-homeostasis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology